nodes	percent_of_prediction	percent_of_DWPC	metapath
Prasugrel—CYP2B6—Doxorubicin—muscle cancer	0.147	0.313	CbGbCtD
Prasugrel—ALB—Methotrexate—muscle cancer	0.14	0.297	CbGbCtD
Prasugrel—CYP3A4—Vincristine—muscle cancer	0.0724	0.154	CbGbCtD
Prasugrel—CYP3A4—Etoposide—muscle cancer	0.0664	0.141	CbGbCtD
Prasugrel—CYP3A4—Doxorubicin—muscle cancer	0.0453	0.0961	CbGbCtD
Prasugrel—Pericardial effusion—Methotrexate—muscle cancer	0.016	0.0303	CcSEcCtD
Prasugrel—Haematochezia—Doxorubicin—muscle cancer	0.0141	0.0267	CcSEcCtD
Prasugrel—Pericardial effusion—Doxorubicin—muscle cancer	0.0139	0.0263	CcSEcCtD
Prasugrel—Gingival bleeding—Doxorubicin—muscle cancer	0.01	0.019	CcSEcCtD
Prasugrel—Pain in extremity—Vincristine—muscle cancer	0.00984	0.0186	CcSEcCtD
Prasugrel—Hyperlipidaemia—Doxorubicin—muscle cancer	0.0079	0.0149	CcSEcCtD
Prasugrel—Haemoptysis—Doxorubicin—muscle cancer	0.0077	0.0146	CcSEcCtD
Prasugrel—Urinary tract disorder—Vincristine—muscle cancer	0.00672	0.0127	CcSEcCtD
Prasugrel—Urethral disorder—Vincristine—muscle cancer	0.00667	0.0126	CcSEcCtD
Prasugrel—Neoplasm malignant—Doxorubicin—muscle cancer	0.00667	0.0126	CcSEcCtD
Prasugrel—Rectal haemorrhage—Doxorubicin—muscle cancer	0.00631	0.0119	CcSEcCtD
Prasugrel—Angiopathy—Vincristine—muscle cancer	0.00618	0.0117	CcSEcCtD
Prasugrel—Mediastinal disorder—Vincristine—muscle cancer	0.00614	0.0116	CcSEcCtD
Prasugrel—Anaemia—Dactinomycin—muscle cancer	0.00613	0.0116	CcSEcCtD
Prasugrel—Ecchymosis—Methotrexate—muscle cancer	0.00595	0.0112	CcSEcCtD
Prasugrel—Neoplasm—Methotrexate—muscle cancer	0.00595	0.0112	CcSEcCtD
Prasugrel—Leukopenia—Dactinomycin—muscle cancer	0.00594	0.0112	CcSEcCtD
Prasugrel—Back pain—Vincristine—muscle cancer	0.00573	0.0108	CcSEcCtD
Prasugrel—Anaemia—Vincristine—muscle cancer	0.00548	0.0104	CcSEcCtD
Prasugrel—Urinary tract disorder—Etoposide—muscle cancer	0.00545	0.0103	CcSEcCtD
Prasugrel—Urethral disorder—Etoposide—muscle cancer	0.00541	0.0102	CcSEcCtD
Prasugrel—Leukopenia—Vincristine—muscle cancer	0.0053	0.01	CcSEcCtD
Prasugrel—Thrombocytopenia—Dactinomycin—muscle cancer	0.0053	0.01	CcSEcCtD
Prasugrel—Eye disorder—Etoposide—muscle cancer	0.00515	0.00975	CcSEcCtD
Prasugrel—Ecchymosis—Doxorubicin—muscle cancer	0.00515	0.00974	CcSEcCtD
Prasugrel—Neoplasm—Doxorubicin—muscle cancer	0.00515	0.00974	CcSEcCtD
Prasugrel—Hypertension—Vincristine—muscle cancer	0.00512	0.00968	CcSEcCtD
Prasugrel—Angiopathy—Etoposide—muscle cancer	0.005	0.00946	CcSEcCtD
Prasugrel—Immune system disorder—Etoposide—muscle cancer	0.00498	0.00942	CcSEcCtD
Prasugrel—Mediastinal disorder—Etoposide—muscle cancer	0.00497	0.0094	CcSEcCtD
Prasugrel—Cerebrovascular accident—Methotrexate—muscle cancer	0.00487	0.00921	CcSEcCtD
Prasugrel—Anaphylactic shock—Vincristine—muscle cancer	0.00484	0.00915	CcSEcCtD
Prasugrel—Thrombocytopenia—Vincristine—muscle cancer	0.00474	0.00895	CcSEcCtD
Prasugrel—Fatigue—Dactinomycin—muscle cancer	0.00467	0.00883	CcSEcCtD
Prasugrel—Back pain—Etoposide—muscle cancer	0.00464	0.00878	CcSEcCtD
Prasugrel—Hypotension—Vincristine—muscle cancer	0.00452	0.00855	CcSEcCtD
Prasugrel—Anaemia—Etoposide—muscle cancer	0.00444	0.00839	CcSEcCtD
Prasugrel—Leukopenia—Etoposide—muscle cancer	0.0043	0.00813	CcSEcCtD
Prasugrel—Body temperature increased—Dactinomycin—muscle cancer	0.00428	0.00809	CcSEcCtD
Prasugrel—Cerebrovascular accident—Doxorubicin—muscle cancer	0.00422	0.00798	CcSEcCtD
Prasugrel—Cough—Etoposide—muscle cancer	0.00419	0.00792	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Vincristine—muscle cancer	0.00418	0.0079	CcSEcCtD
Prasugrel—Fatigue—Vincristine—muscle cancer	0.00417	0.00789	CcSEcCtD
Prasugrel—Hypertension—Etoposide—muscle cancer	0.00414	0.00784	CcSEcCtD
Prasugrel—Pain in extremity—Doxorubicin—muscle cancer	0.00413	0.00782	CcSEcCtD
Prasugrel—Gastrointestinal haemorrhage—Doxorubicin—muscle cancer	0.00413	0.00782	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.00406	0.00768	CcSEcCtD
Prasugrel—Hypersensitivity—Dactinomycin—muscle cancer	0.00399	0.00754	CcSEcCtD
Prasugrel—Anaphylactic shock—Etoposide—muscle cancer	0.00392	0.00741	CcSEcCtD
Prasugrel—Asthenia—Dactinomycin—muscle cancer	0.00388	0.00734	CcSEcCtD
Prasugrel—Thrombocytopenia—Etoposide—muscle cancer	0.00384	0.00725	CcSEcCtD
Prasugrel—Body temperature increased—Vincristine—muscle cancer	0.00382	0.00723	CcSEcCtD
Prasugrel—Skin disorder—Etoposide—muscle cancer	0.00381	0.0072	CcSEcCtD
Prasugrel—Diarrhoea—Dactinomycin—muscle cancer	0.0037	0.007	CcSEcCtD
Prasugrel—Hypotension—Etoposide—muscle cancer	0.00366	0.00692	CcSEcCtD
Prasugrel—Hypersensitivity—Vincristine—muscle cancer	0.00356	0.00674	CcSEcCtD
Prasugrel—Haematuria—Methotrexate—muscle cancer	0.00351	0.00663	CcSEcCtD
Prasugrel—Dyspnoea—Etoposide—muscle cancer	0.00349	0.00661	CcSEcCtD
Prasugrel—Epistaxis—Methotrexate—muscle cancer	0.00347	0.00656	CcSEcCtD
Prasugrel—Asthenia—Vincristine—muscle cancer	0.00347	0.00656	CcSEcCtD
Prasugrel—Rash—Dactinomycin—muscle cancer	0.00341	0.00645	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Etoposide—muscle cancer	0.00338	0.0064	CcSEcCtD
Prasugrel—Fatigue—Etoposide—muscle cancer	0.00338	0.00639	CcSEcCtD
Prasugrel—Haemoglobin—Methotrexate—muscle cancer	0.00332	0.00628	CcSEcCtD
Prasugrel—Diarrhoea—Vincristine—muscle cancer	0.00331	0.00626	CcSEcCtD
Prasugrel—Haemorrhage—Methotrexate—muscle cancer	0.0033	0.00625	CcSEcCtD
Prasugrel—Urinary tract disorder—Methotrexate—muscle cancer	0.00326	0.00617	CcSEcCtD
Prasugrel—Urethral disorder—Methotrexate—muscle cancer	0.00324	0.00612	CcSEcCtD
Prasugrel—Nausea—Dactinomycin—muscle cancer	0.00322	0.00608	CcSEcCtD
Prasugrel—Dizziness—Vincristine—muscle cancer	0.0032	0.00605	CcSEcCtD
Prasugrel—Body temperature increased—Etoposide—muscle cancer	0.0031	0.00586	CcSEcCtD
Prasugrel—Eye disorder—Methotrexate—muscle cancer	0.00309	0.00584	CcSEcCtD
Prasugrel—Rash—Vincristine—muscle cancer	0.00305	0.00577	CcSEcCtD
Prasugrel—Dermatitis—Vincristine—muscle cancer	0.00305	0.00576	CcSEcCtD
Prasugrel—Haematuria—Doxorubicin—muscle cancer	0.00304	0.00574	CcSEcCtD
Prasugrel—Headache—Vincristine—muscle cancer	0.00303	0.00573	CcSEcCtD
Prasugrel—Epistaxis—Doxorubicin—muscle cancer	0.00301	0.00568	CcSEcCtD
Prasugrel—Angiopathy—Methotrexate—muscle cancer	0.003	0.00567	CcSEcCtD
Prasugrel—Immune system disorder—Methotrexate—muscle cancer	0.00298	0.00564	CcSEcCtD
Prasugrel—Mediastinal disorder—Methotrexate—muscle cancer	0.00298	0.00563	CcSEcCtD
Prasugrel—Bradycardia—Doxorubicin—muscle cancer	0.00291	0.00551	CcSEcCtD
Prasugrel—Hypersensitivity—Etoposide—muscle cancer	0.00289	0.00546	CcSEcCtD
Prasugrel—Haemoglobin—Doxorubicin—muscle cancer	0.00287	0.00544	CcSEcCtD
Prasugrel—Nausea—Vincristine—muscle cancer	0.00287	0.00543	CcSEcCtD
Prasugrel—Haemorrhage—Doxorubicin—muscle cancer	0.00286	0.00541	CcSEcCtD
Prasugrel—Urinary tract disorder—Doxorubicin—muscle cancer	0.00282	0.00534	CcSEcCtD
Prasugrel—Oedema peripheral—Doxorubicin—muscle cancer	0.00282	0.00533	CcSEcCtD
Prasugrel—Asthenia—Etoposide—muscle cancer	0.00281	0.00532	CcSEcCtD
Prasugrel—Urethral disorder—Doxorubicin—muscle cancer	0.0028	0.0053	CcSEcCtD
Prasugrel—Back pain—Methotrexate—muscle cancer	0.00278	0.00526	CcSEcCtD
Prasugrel—Diarrhoea—Etoposide—muscle cancer	0.00268	0.00507	CcSEcCtD
Prasugrel—Eye disorder—Doxorubicin—muscle cancer	0.00267	0.00505	CcSEcCtD
Prasugrel—Anaemia—Methotrexate—muscle cancer	0.00266	0.00503	CcSEcCtD
Prasugrel—Angiopathy—Doxorubicin—muscle cancer	0.0026	0.00491	CcSEcCtD
Prasugrel—Dizziness—Etoposide—muscle cancer	0.00259	0.0049	CcSEcCtD
Prasugrel—Immune system disorder—Doxorubicin—muscle cancer	0.00258	0.00489	CcSEcCtD
Prasugrel—Mediastinal disorder—Doxorubicin—muscle cancer	0.00258	0.00487	CcSEcCtD
Prasugrel—Leukopenia—Methotrexate—muscle cancer	0.00257	0.00487	CcSEcCtD
Prasugrel—Cough—Methotrexate—muscle cancer	0.00251	0.00474	CcSEcCtD
Prasugrel—Rash—Etoposide—muscle cancer	0.00247	0.00467	CcSEcCtD
Prasugrel—Dermatitis—Etoposide—muscle cancer	0.00247	0.00467	CcSEcCtD
Prasugrel—Headache—Etoposide—muscle cancer	0.00245	0.00464	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.00243	0.0046	CcSEcCtD
Prasugrel—Back pain—Doxorubicin—muscle cancer	0.00241	0.00455	CcSEcCtD
Prasugrel—Anaphylactic shock—Methotrexate—muscle cancer	0.00235	0.00444	CcSEcCtD
Prasugrel—Nausea—Etoposide—muscle cancer	0.00233	0.0044	CcSEcCtD
Prasugrel—Anaemia—Doxorubicin—muscle cancer	0.0023	0.00435	CcSEcCtD
Prasugrel—Thrombocytopenia—Methotrexate—muscle cancer	0.0023	0.00435	CcSEcCtD
Prasugrel—Skin disorder—Methotrexate—muscle cancer	0.00228	0.00431	CcSEcCtD
Prasugrel—Leukopenia—Doxorubicin—muscle cancer	0.00223	0.00421	CcSEcCtD
Prasugrel—Hypotension—Methotrexate—muscle cancer	0.00219	0.00415	CcSEcCtD
Prasugrel—Cough—Doxorubicin—muscle cancer	0.00217	0.00411	CcSEcCtD
Prasugrel—Hypertension—Doxorubicin—muscle cancer	0.00215	0.00407	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.00211	0.00398	CcSEcCtD
Prasugrel—Dyspnoea—Methotrexate—muscle cancer	0.00209	0.00396	CcSEcCtD
Prasugrel—Anaphylactic shock—Doxorubicin—muscle cancer	0.00203	0.00384	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Methotrexate—muscle cancer	0.00203	0.00383	CcSEcCtD
Prasugrel—Fatigue—Methotrexate—muscle cancer	0.00202	0.00383	CcSEcCtD
Prasugrel—Thrombocytopenia—Doxorubicin—muscle cancer	0.00199	0.00376	CcSEcCtD
Prasugrel—Skin disorder—Doxorubicin—muscle cancer	0.00197	0.00373	CcSEcCtD
Prasugrel—Hypotension—Doxorubicin—muscle cancer	0.0019	0.00359	CcSEcCtD
Prasugrel—Body temperature increased—Methotrexate—muscle cancer	0.00186	0.00351	CcSEcCtD
Prasugrel—Dyspnoea—Doxorubicin—muscle cancer	0.00181	0.00343	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.00175	0.00332	CcSEcCtD
Prasugrel—Fatigue—Doxorubicin—muscle cancer	0.00175	0.00331	CcSEcCtD
Prasugrel—Hypersensitivity—Methotrexate—muscle cancer	0.00173	0.00327	CcSEcCtD
Prasugrel—Asthenia—Methotrexate—muscle cancer	0.00168	0.00318	CcSEcCtD
Prasugrel—Body temperature increased—Doxorubicin—muscle cancer	0.00161	0.00304	CcSEcCtD
Prasugrel—Diarrhoea—Methotrexate—muscle cancer	0.00161	0.00304	CcSEcCtD
Prasugrel—Dizziness—Methotrexate—muscle cancer	0.00155	0.00293	CcSEcCtD
Prasugrel—Hypersensitivity—Doxorubicin—muscle cancer	0.0015	0.00283	CcSEcCtD
Prasugrel—Rash—Methotrexate—muscle cancer	0.00148	0.0028	CcSEcCtD
Prasugrel—Dermatitis—Methotrexate—muscle cancer	0.00148	0.0028	CcSEcCtD
Prasugrel—Headache—Methotrexate—muscle cancer	0.00147	0.00278	CcSEcCtD
Prasugrel—Asthenia—Doxorubicin—muscle cancer	0.00146	0.00276	CcSEcCtD
Prasugrel—Nausea—Methotrexate—muscle cancer	0.00139	0.00264	CcSEcCtD
Prasugrel—Diarrhoea—Doxorubicin—muscle cancer	0.00139	0.00263	CcSEcCtD
Prasugrel—Dizziness—Doxorubicin—muscle cancer	0.00134	0.00254	CcSEcCtD
Prasugrel—Rash—Doxorubicin—muscle cancer	0.00128	0.00242	CcSEcCtD
Prasugrel—Dermatitis—Doxorubicin—muscle cancer	0.00128	0.00242	CcSEcCtD
Prasugrel—Headache—Doxorubicin—muscle cancer	0.00127	0.00241	CcSEcCtD
Prasugrel—Nausea—Doxorubicin—muscle cancer	0.00121	0.00228	CcSEcCtD
